https://medicalxpress.com/urology-news/ en-us Latest medical news and research in Urology An elevated PSA level in the blood may indicate prostate cancer but does not allow for a definitive diagnosis. Where there is a corresponding suspicion, a tissue sample is usually taken from the prostate. A study by the Medical University of Vienna now shows that a specialized form of imaging—known as PSMA-PET/CT—could provide important additional information even before such a biopsy is carried out. https://medicalxpress.com/news/2026-09-prostate-cancer-specialized-imaging-unnecessary.html Tue, 15 Sep 2026 17:40:07 EDT news708704822 Combining the targeted therapy olaparib with an additional immunotherapy may improve immune response in a subgroup of patients with metastatic castration-resistant prostate cancer who responded poorly to initial treatment, according to a Northwestern Medicine study published in The Journal of Clinical Investigation. https://medicalxpress.com/news/2026-09-combination-therapy-immune-response-advanced.html Thu, 10 Sep 2026 15:00:01 EDT news708262756 Prostate cancer is the second most common form of cancer among men globally. Yet, we still know relatively little about why the disease develops or why some men live with it for years while it progresses aggressively in others. https://medicalxpress.com/news/2026-09-dna-signatures-reveal-prostate-cancers.html Wed, 09 Sep 2026 11:00:20 EDT news708169081 Many prostate cancers depend on androgen hormones, including testosterone, to grow. That is why treatments for advanced disease often try to reduce testosterone production or block its effects. Now, scientists have identified an unexpected participant in androgen chemistry: a bacterium from the human urinary tract that can convert the steroid precursor DHEA into testosterone under laboratory conditions. https://medicalxpress.com/news/2026-09-bacteria-testosterone-prostate-cancer.html Mon, 07 Sep 2026 09:00:04 EDT news707989741 A lab-grown micro bladder may explain why urinary tract infections (UTIs) return so frequently, according to a study led by researchers at UCL, the University of Oxford and the University of Leicester. https://medicalxpress.com/news/2026-09-micro-bladder-clues-recurrent-utis.html Fri, 04 Sep 2026 05:00:01 EDT news707653211 Men are likely to suffer more extensive heart attacks than women. Studies have shown that male sex hormones, such as testosterone, intensify inflammation during an acute heart attack and lead to a larger area of damage. According to a study from the University of Gothenburg, patients treated with medication for benign prostatic hyperplasia at the time of a severe acute heart attack experienced fewer serious complications from the attack. https://medicalxpress.com/news/2026-08-prostate-medication-linked-complications-heart.html Wed, 26 Aug 2026 10:00:03 EDT news706954621 Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) with moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT) for patients with localized intermediate-risk prostate cancer indicate that SBRT improved bowel health-related quality of life (HRQOL) in this patient population. There was no significant improvement with SBRT in the other primary objectives, including urinary HRQOL and disease-free survival. These results are now published in the JAMA following their presentation during the Plenary Session of the 2025 American Society for Radiation Oncology Annual Meeting in San Francisco. https://medicalxpress.com/news/2026-08-session-prostate-bowel-quality-life.html Tue, 25 Aug 2026 14:40:03 EDT news706882681 Bladder cancer claims 220,000 lives globally each year, with symptoms sometimes mistaken for other conditions such as kidney stones. Now researchers have developed an artificial intelligence system that can identify bladder cancer patients up to five years before their official diagnosis, potentially revolutionizing screening for the disease. https://medicalxpress.com/news/2026-08-bladder-cancer-years-diagnosis-ai.html Tue, 25 Aug 2026 10:40:05 EDT news706868999 About 1 in 8 men are diagnosed with prostate cancer during their lifetime. Although many survive, it can develop into metastatic disease. https://medicalxpress.com/news/2026-08-drug-combination-advanced-prostate-cancer.html Fri, 21 Aug 2026 12:00:03 EDT news706528627 Prostate tumors can rewire amino acid metabolism to override the normal brakes on cholesterol production, a process that may fuel hormone therapy resistance, according to a study by Weill Cornell Medicine investigators. https://medicalxpress.com/news/2026-08-prostate-cancer-hijacks-amino-acid.html Thu, 20 Aug 2026 11:00:12 EDT news706368901 As focal therapy gains popularity as a less invasive treatment option for some men with prostate cancer, a national study led by researchers at the University of Pittsburgh found that some men may be receiving treatment that is either unnecessary or not aggressive enough for their cancer. https://medicalxpress.com/news/2026-08-prostate-cancer-focal-therapy-fall.html Thu, 13 Aug 2026 11:00:07 EDT news705671341 Three decades after UC San Francisco pioneered "active surveillance" for patients with low-risk prostate cancer, a new study has found that the vast majority of veterans with the diagnosis pursued this option instead of treatment. https://medicalxpress.com/news/2026-08-early-prostate-cancer-surveillance-choice.html Thu, 13 Aug 2026 11:00:04 EDT news705833174 After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that treatment is working. A recent real-world study indicates that reaching a PSA level below 0.2 ng/mL is an indicator of improved patient survival. The study is published online in CANCER. https://medicalxpress.com/news/2026-08-prostate-cancer-prognosis-linked-specific.html Mon, 10 Aug 2026 03:10:01 EDT news705243845 Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a Phase III clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center and investigators at several other institutions worldwide. https://medicalxpress.com/news/2026-08-radiopharmaceutical-benefit-patients-metastatic-prostate.html Fri, 07 Aug 2026 13:20:05 EDT news705324093 An erectile dysfunction drug that is also used to treat symptoms, such as sudden urgency and frequency, associated with an enlarged prostate in men may heighten the risk of glaucoma, a serious eye condition, a large comparative study published online in the British Journal of Ophthalmology finds. https://medicalxpress.com/news/2026-08-erectile-dysfunction-drug-enlarged-prostate.html Tue, 04 Aug 2026 18:30:01 EDT news704965160 UCLA researchers have identified a promising strategy to make a new class of targeted cancer therapies more effective against one of the deadliest forms of prostate cancer, potentially overcoming treatment resistance that has limited their success. https://medicalxpress.com/news/2026-08-combination-therapies-treatment-resistance-advanced.html Tue, 04 Aug 2026 13:00:10 EDT news705062642 Australian researchers have discovered a previously overlooked group of bladder nerves that help detect urinary tract infections (UTIs) and trigger the body's response to clear them, providing a potential new target for future bladder pain therapies. https://medicalxpress.com/news/2026-08-uti-good.html Tue, 04 Aug 2026 12:40:03 EDT news705062341